Single Dose Trial of VMX-C001 in Healthy Subjects with and Without FXa Direct Oral Anticoagulant

NCT06372483 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Coagulation Disorder

Interventions

DRUG: VMX-C001
DRUG: Placebo
DRUG: Rivaroxaban 20 mg Oral Tablet
DRUG: Apixaban 5 mg Oral Tablet
DRUG: Edoxaban 60 mg Oral Tablet

Sponsor

VarmX B.V.